{"disease":{"id":"herpangina","name":"herpangina"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06263439","title":"Surveillance of HFMD in Pediatric Outpatients","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT06063057","title":"Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":744,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT03266601","title":"Effect of Recombinant Human Interferon α-2b Spray on Herpangina","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":668,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT06754384","title":"Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":552,"lead_sponsor_name":"Sinovac Biotech Co., Ltd","has_results":false},{"nct_id":"NCT03241030","title":"Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"University of Texas at Austin","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}